Ahmed Hamdy Md.
Chief Medical Officer, Pharmacyclics.
Companies
- CURIS INCCMO May 5, 2025 to now1
- Vincerx Pharma, Inc.Board member Dec 28, 2020 to Aug 14, 20242
- Vincerx Pharma, Inc.Chief executive officer Dec 28, 2020 to Aug 14, 20242
- Vincerx Pharma, Inc.Officer Aug 10, 2023 to Aug 10, 20233
- Vincerx Pharma, Inc.President Dec 28, 2020 to Dec 28, 20202
- PharmacyclicsChief Medical Officer Mar 12, 2009 to May 3, 20114
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CURIS INC CRIS66,667 shares5$25.3K at $0.38Mar 20, 2026
- Vincerx Pharma, Inc.1,714,259 shares6Aug 10, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 20, 2026Converted 66,667 shares of CURIS INC5
- Aug 10, 2023Bought 5,400 shares at $0.96 of Vincerx Pharma, Inc.6
- Aug 9, 2023Bought 16,900 shares at $0.95 of Vincerx Pharma, Inc.6
- Dec 14, 2022Bought 35,280 shares at $0.87 of Vincerx Pharma, Inc.7
- Jun 23, 2022Bought 24,200 shares at $1.41 of Vincerx Pharma, Inc.8
- Dec 22, 2021Bought 6,450 shares at $10.02 of Vincerx Pharma, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCURIS INC, CMO
- 2SEC EDGARVincerx Pharma, Inc., Board member
- 3SEC EDGARVincerx Pharma, Inc., Officer
- 4SEC EDGARPharmacyclics, Chief Medical Officer
- 5
- 6
- 7SEC EDGARForm 4 filed Dec 14, 2022
- 8SEC EDGARForm 4 filed Jun 27, 2022
- 9SEC EDGARForm 4 filed Dec 27, 2021